Naproxen Hualan Pharmaceuticals (Naproxen Bp)

Naproxen works by inhibiting both COX‑1 and COX‑2 enzymes, which are essential for the production of prostaglandins. By reducing prostaglandin synthesis, naproxen decreases the inflammatory response, lowers pain signaling, and helps normalize body temperature during fever.

The specific dose of naproxen is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and overall health status. Dosage regimens can vary, and the prescriber will provide individualized instructions.

Safety of naproxen in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Naproxen has a longer half‑life than ibuprofen, allowing for less frequent dosing, which can improve adherence. Both drugs share similar mechanisms of COX inhibition, but naproxen may carry a slightly higher risk of gastrointestinal irritation, while ibuprofen is often associated with a higher incidence of short‑term cardiovascular effects. Choice depends on individual patient factors and clinician judgment.

Naproxen tablets should be stored at room temperature, ideally below 25 °C. Keep them in the original container, protect from moisture, heat and direct sunlight to maintain product stability throughout its shelf life.

Naproxen is administered orally, typically as a tablet or capsule, and should be taken with a full glass of water. It can be taken with food or milk to lessen gastrointestinal discomfort, unless otherwise directed by the prescriber.

The most serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, and renal impairment that can lead to acute kidney injury. Patients should be monitored for signs of these conditions, especially if they have pre‑existing risk factors.

Individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, uncontrolled hypertension, or advanced renal or hepatic impairment should not use naproxen. Pregnant women in the third trimester and patients on certain anticoagulants should also avoid it unless specifically advised by a physician.